Return to homepagePandemic Pact

to deliver drug candidates to be developed for treatment of coronavirus infections including SARS-CoV-2

Grant number: INV-033028

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021

  • Known Financial Commitments (USD)

    $2,958,995

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Novartis Institutes for BioMedical Research, Inc.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A